Interleukin-1α, interleukin 6 and tumor necrosis factor α increase the synthesis and expression of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro

APMIS

Volumn 104, Issue 3, 1996, Pages 213-219

  Berge, V ^a   Johnson, E ^a   Berge, K E ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

C3; Cytokines; EC; TCC

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; COMPLEMENT COMPONENT C6; INTERLEUKIN 1ALPHA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; CULTURE MEDIUM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; STIMULATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN CELL; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; SEPSIS;

CELLS, CULTURED; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT FACTOR B; COMPLEMENT MEMBRANE ATTACK COMPLEX; CULTURE MEDIA, SERUM-FREE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; STIMULATION, CHEMICAL; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0029665104     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb00710.x     Document Type: Article

References (27)

1. Berge, V., Berge, K. E. & Johnson, E.: Vitronectin modulates the expression of the terminal complement pathway synthesized by human umbilical vein endothelial cells in vitro. APMIS: 1996. (In press).
2. Berge, V., Johnson, E. & Nazir, M.: Effect of gamma-interferon on the synthesis of the functional alternative and terminal complement pathways by human umbilical vein endothelial cells in vitro. APMIS 102: 554-558, 1994.
3. Brooimans, R., A., van der Ark, A. A., Buurman, W. A., van Es, L. A. & Doha, M. R.: Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by INF-γ and IL-1. J. Immunol. 144: 3835-3840, 1990.
4. Brooimans, R. A., Heimstra, P. S., van der Ark, A. A., Sim, R. B., van Es, L. A. & Daha, M. R.: Biosynthesis of complement factor H by human umbilical vein endothelial cells. J. Immunol. 142: 2024-2030, 1989.
5. Coulpier, M., Andrew, S., Lemercier, C., Dauchel, H., Lees, O., Fontaine, M. & Ripoehe, J.: Activation of the endothelium by IL-1α and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a. Clin. Exp. Immunol. 101: 142-149, 1995.
6. Cozzolino, F., Torcia, M., Aldinucci, D., Ziche, M., Almerigogna, F., Bani, D. & Stern, D. M.: Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc. Natl. Acad. Sci. 87: 6487-6491, 1990.
7. De Boer, J. P., Wolbink, G. J., Lambertus, G. T., Baars, J. W., Wagstaff, J. & Hack, C. E.: Interplay of complement and cytokines in the pathogenesis of septic shock. Immunopharmacology 24: 135-148, 1992.
8. Gasque, P., Julen, J., Ischenko, A. M., Picot, C., Mauger, C., Chauzy, C., Ripoche, J. & Fontaine, M.: Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol. 149: 1381-1387, 1992.
9. Girardin, E., Grau, G. E., Dayer, J. M. & Roux-Lambard, P.: Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319: 397-400, 1988.
10. Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R.: Culture of human endothelial cells derived from umbilical veins. Identification by morphological and immunological criteria. J. Clin. Invest. 52: 2745-2752, 1973.
11. Johnson, E. & Hetland, G.: A sensitive method to detect synthesis of the functional classical, alternative and terminal pathway of complement by cells cultured in vitro. Scand. J. Clin. Lab. Invest. 48: 223-231, 1988.
12. Johnson, E. & Hetland, G.: Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro. Scand. J. Immunol. 33: 667-671, 1991.
13. Johnson, E., Berge, V. & Hogåsen, K.: Formation of the terminal complement complex on agarose beads: Further evidence that vitronectin (complement S-protein) inhibits C9 polymerization. Scand. J. Immunol. 39: 281-285, 1994.
14. Katz, Y., Guterman, M. & Lahart, E.: Regulation of synthesis of complement proteins in Hep2 cells. Clin. Immunol. Immunopathol. 67: 117-123, 1993.
15. 2/IL-6 genes in human fibroblasts. J. Immunol. 142: 3862-3867, 1989.
16. Kilgore, K. S., Shen, J. P., Miller, B. F., Ward, P. A. & Warren, J. S.: Enchancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 155: 1434-1441, 1995.
17. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T. & Zinkernagel Bluethmann, H. & Kohler, G.: Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339-342, 1994.
18. Kushner, I. & Mackiewicz, A.: Acute phase proteins as disease markers. Dis. Markers 5: 1-11, 1986.
19. McCabe, W. R., Treadwell, T. L. & De Maria Jr., A.: Pathophysiology of bacteremia. Am. J. Med. 75: 7-18, 1983.
20. McPhaden, A. R. & Whaley, K.: Complement biosynthesis by mononuclear phagocytes. Immunol. Res. 12: 213-232, 1993.
21. Mollnes, T. E., Lea, T., Harboe, M. & Tschopp, J.: Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma. Scand. J. Immunol. 93: 409-420, 1983.
22. Pettersen, H. B., Johnson, E. & Hetland, G.: Human alveolar macrophages synthesize active complement components C6, C7 and C8 in vitro. Scand. J. Immunol. 25: 567-570, 1987.
23. Perissutti, S. & Tedesco, F.: Effect of cytokines on the secretion of the fifth and eighth complement components by HepG2 cells. Int. J. Clin. Lab. Res. 24: 45-48, 1994.
24. Ripoche, J., Mitchell, J. A., Erdei, A., Madin, C., Moffatt, B., Mokoena, T., Gordon, S. & Sim, R. B.: Interferon γ induces synthesis of complement alternative pathway proteins by human endothelial cells in culture. Eur. J. Immunol. 22: 213-217, 1992.
25. Schonermark, M., Deppisch, R., Riedasch, G., Rother, K. & Hanch, G. M.: Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int. Arch. Allergy. Appl. Immunol. 96: 331-337, 1992.
26. Stites, D. P. & Terr, A. I.: Basic and Clinical Immunology. Seventh Edition. Lange Medical Publication, Connecticut 1991, pp. 78-100.
27. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R., Fahey, T. J., Zentella, A., Albert, J. D., Shires, G. T. & Cerami, A.: Shock and tissue injury induced by human recombinant cachectin. Science 234: 470-474, 1986